Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC gynaecological cancer cooperative group study

Gynecologic Oncology

Volumn 81, Issue 3, 2001, Pages 348-354

  Wagenaar, H C ^a,b   Colombo, N ^c   Vergote, I ^d   Hoctin Boes, G ^b   Zanetta, G ^e   Pecorelli, S ^f   Lacave, A J ^g   Van Hoesel, Q ^h   Cervantes, A ⁱ   Bolis, G ^j   Namer, M ^k   Lhomme C ^l   Guastalla, J P ^m   Nooij, M A ^a   Poveda, A ⁿ   Scotto di Palumbo, V ^o   Vermorken, J B ^p  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e SAN GERARDO HOSPITAL   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k CENTRE ANTOINE LACASSAGNE   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m CENTRE LÉON BÉRARD   (France)

ⁿ INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^o SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^p ANTWERP UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

Bleomycin; Cancer; CCNU; Chemotherapy; Methotrexate; Phase II trial; Vulva

Indexed keywords

BLEOMYCIN; LOMUSTINE; METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LUNG TOXICITY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; VULVA CARCINOMA; VULVECTOMY;

EID: 0034989545     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6180     Document Type: Article

References (30)

1. Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)
2. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma
3. Carcinoma of the vulva
4. Carcinoma of the vulva: Analysis of treatment failures
5. Carcinoma of the vulva
6. Low dose bleomycin and methotrexate in cervical cancer
7. Clinical studies with nitrosoureas in various solid tumours
8. Response of mammalian cells following treatment with bleomycin and 1,3-bis-(2-chloroethyl)-1-nitrosourea during plateau phase
9. Reporting results of cancer treatment
10. The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapy agent
11. Nonparametric estimation from incomplete observations
12. Chemotherapy of squamous cell carcinoma of the vulva: A review
13. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: A high incidence of pulmonary toxicity
14. Seven-drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract
15. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent cell carcinoma of the vulva
16. Bleomycin therapy in advanced Hodgkin's disease and epidermoid cancers
17. Methotrexate, hydroxyurea, and vincristine: Combination chemotherapy in squamous carcinoma of the female genitalia
18. Combination chemotherapy with Adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases
19. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery
20. Cervix cancer: Treatment with combination vincristine and high doses of methotrexate
21. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas
22. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C and cisplatin (BOMP) for a patient with inoperable vulvar cancer
23. A bleomycin/ifosfamide/ cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers
24. Treatment of cervical carcinoma with methotrexate, bleomycin and vincristine
25. Combination chemotherapy with bleomycin and methotrexate in recurrent and disseminated cervical carcinoma: A preliminary study
26. Preoperative chemoradiation for advanced vulvar cancer: A phase II study for the Gynecologic Oncology Group
27. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma
28. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study
29. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer
30. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva